Roy, R., Schumacher, S., Murphy, H. C., Grondolsky, J., Chuprun, K., Waldschmidt, H. V., … Koch, W. (2023). Therapeutic Efficacy of a Novel Pharmacologic GRK2 Inhibitor in Mice Models of Heart Failure. In The Journal of Pharmacology and Experimental Therapeutics (Vol. 385, pp. 104–104). Elsevier BV. https://doi.org/10.1124/jpet.122.525250

Roy, Rajika, Sarah Schumacher, Haley C. Murphy, Jessica Grondolsky, Kurt Chuprun, Helen V. Waldschmidt, Erhe Gao, et al. “Therapeutic Efficacy of a Novel Pharmacologic GRK2 Inhibitor in Mice Models of Heart Failure.” In The Journal of Pharmacology and Experimental Therapeutics, 385:104–104. Elsevier BV, 2023. https://doi.org/10.1124/jpet.122.525250.

Roy R, Schumacher S, Murphy HC, Grondolsky J, Chuprun K, Waldschmidt HV, et al. Therapeutic Efficacy of a Novel Pharmacologic GRK2 Inhibitor in Mice Models of Heart Failure. In: The Journal of Pharmacology and Experimental Therapeutics. Elsevier BV; 2023. p. 104–104.

Roy, Rajika, et al. “Therapeutic Efficacy of a Novel Pharmacologic GRK2 Inhibitor in Mice Models of Heart Failure.” The Journal of Pharmacology and Experimental Therapeutics, vol. 385, Elsevier BV, 2023, pp. 104–104. Crossref, doi:10.1124/jpet.122.525250.

Roy R, Schumacher S, Murphy HC, Grondolsky J, Chuprun K, Waldschmidt HV, Gao E, Zhao H, Avramova L, Tesmer JJG, Koch W. Therapeutic Efficacy of a Novel Pharmacologic GRK2 Inhibitor in Mice Models of Heart Failure. The Journal of Pharmacology and Experimental Therapeutics. Elsevier BV; 2023. p. 104–104.